MSD Of India Defends Marketing Of Gardasil Against Cervical Cancer
This article was originally published in PharmAsia News
Executive Summary
India's MSD Pharmaceuticals Private says its marketing of Gardasil vaccine, approved to prevent the human papilloma virus, for other uses is justified given 10 years of research and development
|
India's MSD Pharmaceuticals Private says its marketing of Gardasil vaccine, approved to prevent the human papilloma virus, for other uses is justified given 10 years of research and development. The Indian Academy of Paediatrics Committee on Immunization defended the vaccine, made by Australia's CSL, as necessary to prevent 14 types of cervical cancers. MSD issued the response after criticism of clinical trials for the drug conducted in India violated ethical procedures. (Click here for more) "Pharma Company Clarifies On Effects Of Gardasil Vaccine" - The Hindu (India) (4/9/10) |